Navigation Links
Stroke risk in pregnant women 2.4 times higher
Date:7/8/2011

MAYWOOD, Ill. -- High blood pressure during pregnancy is a leading cause of maternal and fetal mortality worldwide.

Pregnant women face a risk of stroke that is 2.4 times higher than the risk in non-pregnant women, according to a medical journal article by Loyola University Health System researchers.

The review article on pregnancy-induced high-blood-pressure syndromes is published in the journal Women's Health.

"Prompt diagnosis and identification of patients at risk allows for early therapeutic interventions and improved clinical outcomes," the Loyola authors wrote.

Pregnancy-induced high-blood-pressure syndromes include pre-eclampsia, eclampsia and a rare but serious illness called HELLP (hemolysis, elevated liver enzymes and low platelet count).

Pre-eclampsia is a multi-system disorder characterized by high blood pressure (top or bottom numbers equal to or greater than 140/90, when measured on two occasions six hours apart) and proteinuria (excess protein in urine -- more than 300 mg. in 24 hours).

Left untreated, pre-eclampsia can cause serious complications, possibly fatal, in the mother and baby. In severe pre-eclampsia, patients may develop oliguria (reduced urine output), pulmonary edema (fluid in the lungs), liver dysfunction, thrombocytopenia (low platelet count) and changes in mental status and other cerebral symptoms. Patients may have headaches, stupor, visual blurring, blindness (often temporary) or seizures.

Pre-eclampsia can progress to eclampsia or HELLP. Pre-eclampsia develops into eclampsia when a patient experiences convulsive seizures or goes into a coma. HELP can cause bleeding, liver problems and high-blood-pressure problems, harming both mother and baby.

"Pre-eclampsia/eclampsia-related events are a major cause of maternal disability and maternal and fetal death in the USA, and without prompt and aggressive treatment these patients may rapidly decline," the Loyola authors wrote. All four are neurologists in the Loyola Stroke Program.

For pregnant women who have pre-eclampsia risk factors, starting aspirin at 12-to-14 weeks may decrease the risk of pre-eclampsia and death of the baby.

Once a patient is diagnosed with pre-eclampsia/eclampsia, physicians attempt to control blood pressure and seizures and manage brain swelling. "Prompt delivery of a viable baby remains the main and only curative therapeutic intervention," the authors wrote.

Women who have pre-eclampsia are at higher risk for future stroke and cardiovascular disease.

The researchers wrote that identifying patients at risk of pregnancy-induced high blood pressure syndrome remains "a major research focus."


'/>"/>

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Source:Eurekalert

Related medicine news :

1. Citywide study shows racial disparities in emergency stroke treatment
2. Georgetown research identifies key reasons racial disparities exist in emergent stroke treatment
3. Early Talk Therapy May Help Stroke Patients Bounce Back
4. More Olive Oil in Diet Could Cut Stroke Risk: Study
5. Diabetics May Be at Greater Risk for Second Stroke
6. Exercise May Protect the Brain From Silent Strokes
7. Use of clot-busting drug for US stroke patients doubled from 2005 to 2009
8. More Stroke Patients Get Clot-Busting Drug But Barriers Remain
9. U.S. Southeast Stroke Belt Also Shows Higher Rates of Cognitive Decline
10. Experts Say Stroke Care Differs for U.S. Minorities
11. Cognitive decline incidence higher in Southern stroke belt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in New York City, with long-time partners The Paul Foundation, on November 10, ...
(Date:12/4/2016)... ... 04, 2016 , ... "Pro3rd Displace is a set of ... displacement design elements," said Christina Austin - CEO of Pixel Film Studios. ... of design styles that include both left aligned and right aligned options for ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global ... Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New York ... who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the ...
(Date:12/2/2016)... ... 02, 2016 , ... Advanced Inc., a leading provider of travel therapy and ... to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously ... financial and operational leadership experience to Advanced Inc. He began his career in finance ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain management programs ... patients must find the one that works for them. When an inventor from Suisun ... that worked and decided to share it with others. , He developed a prototype ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... N.J. , Dec. 3, 2016  Findings ... and safety of CTL019, an investigational chimeric antigen ... (r/r) pediatric and young adult patients with B-cell ... during an oral session at the 58th American ... December 3, 4:00-5:30 p.m.). The global Phase II ...
(Date:12/2/2016)... bioLytical Laboratories, un líder mundial en test rápidos de ... Self Test , a los miembros de la Kenya Pharmaceutical Association. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ... (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical fue invitada por la Clinton ...
(Date:12/2/2016)... According to the latest market report ... Automated Endoscope Reprocessors: Single Basin Automated Endoscope Reprocessors Product Type ... and 2024 " the global automated endoscope reprocessors market was valued at US$ ... a CAGR of 7.2% during an eight-year forecast period 2016-2024, ... 2024. ...
Breaking Medicine Technology: